Cancer and IgE pp 231-254 | Cite as

The Targets of IgE: Allergen-Associated and Tumor-Associated Molecular Patterns

  • Erika Jensen-JarolimEmail author
  • Diana Mechtcheriakova
  • Isabella Pali-Schoell


The most studied targets of IgE immunoglobulins are termed allergens and mostly represent protein antigens from plant or animal origin. However, it has been revealed that also pathogens and self-antigens can be recognized by IgE. Thus, besides a detrimental role in allergy, IgE may exert defense and surveillance functions. Here, we discuss the display of rigid epitope patterns as a common key feature of antigens leading to both formation of high-affinity IgE antibodies by B lymphocytes and IgE-mediated triggering of effector cells. In analogy to the principle of pathogen-associated patterns as danger signals, we introduce here the terms allergen-associated molecular patterns (AAMPs) for the repetitive epitopes exposed by allergens and tumor-associated molecular patterns (TAMPs) in settings when molecular epitope patterns are displayed through overexpressed tumor antigens.


Epidermal Growth Factor Receptor Lipid Raft Epidermal Growth Factor Receptor Family Tumor Cell Membrane Epitope Density 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



This work was supported by grants of the Austrian Science Fund FWF (P18238-B13, SFB F01808-B13) and by the Ludwig Boltzmann Cluster Oncology, Vienna, Austria. Isabella Pali-Schoell was supported by Herta Firnberg grant T283-B13 of the FWF. Further, we would like to thank Mr. Walter Jarolim, crossip comm, Vienna, Austria, for excellent support in graphic arts.


  1. 1.
    Arias MA, Rey Nores JE, Vita N, Stelter F, Borysiewicz LK, Ferrara P, and Labeta MO (2000) Cutting edge: human B cell function is regulated by interaction with soluble CD14: opposite effects on IgG1 and IgE production. J Immunol 164:3480–6PubMedGoogle Scholar
  2. 2.
    Hantusch B, Scholl I, Harwanegg C, Krieger S, Becker WM, Spitzauer S, Boltz-Nitulescu G, and Jensen-Jarolim E (2005) Affinity determinations of purified IgE and IgG antibodies against the major pollen allergens Phl p 5a and Bet v 1a: discrepancy between IgE and IgG binding strength. Immunol Lett 97:81–9PubMedGoogle Scholar
  3. 3.
    Erazo A, Kutchukhidze N, Leung M, Christ AP, Urban JF Jr, Curotto de Lafaille MA, and Lafaille JJ (2007) Unique maturation program of the IgE response in vivo. Immunity 26:191–203PubMedGoogle Scholar
  4. 4.
    Karagiannis SN, Bracher MG, Beavil RL, Beavil AJ, Hunt J, McCloskey N, Thompson RG, East N, Burke F, Sutton BJ, Dombrowicz D, Balkwill FR, and Gould HJ (2008) Role of IgE receptors in IgE antibody-dependent cytotoxicity and phagocytosis of ovarian tumor cells by human monocytic cells. Cancer Immunol Immunother 57:247–63PubMedGoogle Scholar
  5. 5.
    Gould HJ and Sutton BJ (2008) IgE in allergy and asthma today. Nat Rev Immunol 8: 205–17PubMedGoogle Scholar
  6. 6.
    Peavy RD and Metcalfe DD (2008) Understanding the mechanisms of anaphylaxis. Curr Opin Allergy Clin Immunol 8:310–5PubMedGoogle Scholar
  7. 7.
    Tu Y, Salim S, Bourgeois J, Di Leo V, Irvine EJ, Marshall JK, and Perdue MH (2005) CD23-mediated IgE transport across human intestinal epithelium: inhibition by blocking sites of translation or binding. Gastroenterology 129:928–40PubMedGoogle Scholar
  8. 8.
    Hjelm F, Karlsson MC, and Heyman B (2008) A novel B cell-mediated transport of IgE-immune complexes to the follicle of the spleen. J Immunol 180:6604–10PubMedGoogle Scholar
  9. 9.
    Galli SJ, Kalesnikoff J, Grimbaldeston MA, Piliponsky AM, Williams CM, and Tsai M (2005) Mast cells as “tunable” effector and immunoregulatory cells: recent advances. Annu Rev Immunol 23:749–86PubMedGoogle Scholar
  10. 10.
    Galli SJ, Tsai M, and Piliponsky AM (2008) The development of allergic inflammation. Nature 454:445–54PubMedGoogle Scholar
  11. 11.
    Zehnder JL and Galli SJ (1999) Mast-cell heparin demystified. Nature 400:714–5PubMedGoogle Scholar
  12. 12.
    Untersmayr E, Bakos N, Scholl I, Kundi M, Roth-Walter F, Szalai K, Riemer AB, Ankersmit HJ, Scheiner O, Boltz-Nitulescu G, and Jensen-Jarolim E (2005) Anti-ulcer drugs promote IgE formation toward dietary antigens in adult patients. FASEB J 19:656–8PubMedGoogle Scholar
  13. 13.
    Akdis M (2008) T-cell tolerance to inhaled allergens: mechanisms and therapeutic approaches. Expert Opin Biol Ther 8:769–77PubMedGoogle Scholar
  14. 14.
    Francis JN, James LK, Paraskevopoulos G, Wong C, Calderon MA, Durham SR, and Till SJ (2008) Grass pollen immunotherapy: IL-10 induction and suppression of late responses precedes IgG4 inhibitory antibody activity. J Allergy Clin Immunol 121:1120–25 e2PubMedGoogle Scholar
  15. 15.
    Daeron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, and Fridman WH (1995) The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 3: 635–46PubMedGoogle Scholar
  16. 16.
    Satoguina JS, Adjobimey T, Arndts K, Hoch J, Oldenburg J, Layland LE, and Hoerauf A (2008) Tr1 and naturally occurring regulatory T cells induce IgG4 in B cells through GITR/GITR-L interaction, IL-10 and TGF-beta. Eur J Immunol 38:3101–13PubMedGoogle Scholar
  17. 17.
    Jarnicki AG, Lysaght J, Todryk S, and Mills KH (2006) Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells. J Immunol 177: 896–904PubMedGoogle Scholar
  18. 18.
    Ma HL, Whitters MJ, Jacobson BA, Donaldson DD, Collins M, and Dunussi-Joannopoulos K (2004) Tumor cells secreting IL-13 but not IL-13Ralpha2 fusion protein have reduced tumorigenicity in vivo. Int Immunol 16:1009–17PubMedGoogle Scholar
  19. 19.
    Aspord C, Pedroza-Gonzalez A, Gallegos M, Tindle S, Burton EC, Su D, Marches F, Banchereau J, and Palucka AK (2007) Breast cancer instructs dendritic cells to prime interleukin 13-secreting CD4+ T cells that facilitate tumor development. J Exp Med 204:1037–47PubMedGoogle Scholar
  20. 20.
    Wynn TA (2003) IL-13 effector functions. Annu Rev Immunol 21:425–56PubMedGoogle Scholar
  21. 21.
    Neuchrist C, Kornfehl J, Grasl M, Lassmann H, Kraft D, Ehrenberger K, and Scheiner O (1994) Distribution of immunoglobulins in squamous cell carcinoma of the head and neck. Int Arch Allergy Immunol 104:97–100PubMedGoogle Scholar
  22. 22.
    Fu SL, Pierre J, Smith-Norowitz TA, Hagler M, Bowne W, Pincus MR, Mueller CM, Zenilman ME, and Bluth MH (2008) Immunoglobulin E antibodies from pancreatic cancer patients mediate antibody-dependent cell-mediated cytotoxicity against pancreatic cancer cells. Clin Exp Immunol 153:401–9PubMedGoogle Scholar
  23. 23.
    Jensen-Jarolim E, Achatz G, Turner MC, Karagiannis S, Legrand F, Capron M, Penichet ML, Rodriguez JA, Siccardi AG, Vangelista L, Riemer AB, and Gould H (2008) AllergoOncology: the role of IgE-mediated allergy in cancer. Allergy 63:1255–66PubMedGoogle Scholar
  24. 24.
    Davies DR and Metzger H (1983) Structural basis of antibody function. Annu Rev Immunol 1:87–117PubMedGoogle Scholar
  25. 25.
    Padlan EA, Silverton EW, Sheriff S, Cohen GH, Smith-Gill SJ, and Davies DR (1989) Structure of an antibody-antigen complex: crystal structure of the HyHEL-10 Fab-lysozyme complex. Proc Natl Acad Sci USA 86:5938–42PubMedGoogle Scholar
  26. 26.
    Mirza O, Henriksen A, Ipsen H, Larsen JN, Wissenbach M, Spangfort MD, and Gajhede M (2000) Dominant epitopes and allergic cross-reactivity: complex formation between a Fab fragment of a monoclonal murine IgG antibody and the major allergen from birch pollen Bet v 1. J Immunol 165:331–8PubMedGoogle Scholar
  27. 27.
    Bosshard HR (1996) Epitope mapping by differential chemical modification of antigens. Methods Mol Biol 66:85–95PubMedGoogle Scholar
  28. 28.
    Riemer AB and Jensen-Jarolim E (2007) Mimotope vaccines: epitope mimics induce anti-cancer antibodies. Immunol Lett 113:1–5PubMedGoogle Scholar
  29. 29.
    Szalai K, Jensen-Jarolim E, and Pali-Scholl I (2008) Vaccination strategies based on the mimotope concept. G Ital Dermatol Venereol 143:95–104PubMedGoogle Scholar
  30. 30.
    Knittelfelder R and Jensen-Jarolim E (2009) Mimotope vaccination – from allergy to cancer. Expert Opin Biol Ther 9:1–14Google Scholar
  31. 31.
    Riemer AB, Untersmayr E, Knittelfelder R, Duschl A, Pehamberger H, Zielinski CC, Scheiner O, and Jensen-Jarolim E (2007) Active induction of tumor-specific IgE antibodies by oral mimotope vaccination. Cancer Res 67:3406–11PubMedGoogle Scholar
  32. 32.
    Berglund L, Andrade J, Odeberg J, and Uhlen M (2008) The epitope space of the human proteome. Protein Sci 17:606–13PubMedGoogle Scholar
  33. 33.
    Bell GI (1974) Model for the binding of multivalent antigen to cells. Nature 248:430–1PubMedGoogle Scholar
  34. 34.
    Dintzis HM and Dintzis RZ (1990) Antigens as immunoregulators. Immunol Rev 115:243–50; discussion 251PubMedGoogle Scholar
  35. 35.
    Omori SA, Cato MH, Anzelon-Mills A, Puri KD, Shapiro-Shelef M, Calame K, and Rickert RC (2006) Regulation of class-switch recombination and plasma cell differentiation by phosphatidylinositol 3-kinase signaling. Immunity 25:545–7PubMedGoogle Scholar
  36. 36.
    Monticelli S and Vercelli D (2001) Molecular regulation of class switch recombination to IgE through epsilon germline transcription. Allergy 56:270–8PubMedGoogle Scholar
  37. 37.
    Perona-Wright G, Mohrs K, Taylor J, Zaph C, Artis D, Pearce EJ, and Mohrs M (2008) Cutting edge: Helminth infection induces IgE in the absence of mu- or delta-chain expression. J Immunol 181:6697–701PubMedGoogle Scholar
  38. 38.
    Feldmann M (1972) Induction of immunity and tolerance in vitro by hapten protein conjugates. I. The relationship between the degree of hapten conjugation and the immunogenicity of dinitrophenylated polymerized flagellin. J Exp Med 135:735–53PubMedGoogle Scholar
  39. 39.
    Feldmann M (1972) Induction of immunity and tolerance in vitro by hapten protein conjugates. 3. Hapten inhibition studies of antigen binding to B cells in immunity and tolerance. J Exp Med 136:532–45PubMedGoogle Scholar
  40. 40.
    Katz DH, Hamaoka T, and Benacerraf B (1974) Immunological tolerance in bone marrow-derived lymphocytes. 3. Tolerance induction in primed B cells by hapten conjugates of unrelated immunogenic or “nonimmunogenic” carriers. J Exp Med 139:1464–72PubMedGoogle Scholar
  41. 41.
    Hubbard DA, Lee WY, and Sehon AH (1981) Suppression of the anti-DNP IgE response with tolerogenic conjugates of DNP with polyvinyl alcohol. I. Specific suppression of the anti-DNP IgE response. J Immunol 126:407–13PubMedGoogle Scholar
  42. 42.
    Scholl I, Kopp T, Bohle B, and Jensen-Jarolim E (2006) Biodegradable PLGA particles for improved systemic and mucosal treatment of Type I allergy. Immunol Allergy Clin North Am 26:349–64, ixPubMedGoogle Scholar
  43. 43.
    Feldmann M and Easten A (1971) The relationship between antigenic structure and the requirement for thymus-derived cells in the immune response. J Exp Med 134:103–19PubMedGoogle Scholar
  44. 44.
    Dintzis HM, Dintzis RZ, and Vogelstein B (1976) Molecular determinants of immunogenicity: the immunon model of immune response. Proc Natl Acad Sci USA 73:3671–5PubMedGoogle Scholar
  45. 45.
    Sharma S, Orlowski G, and Song W (2009) Btk regulates B cell receptor-mediated antigen processing and presentation by controlling actin cytoskeleton dynamics in B cells. J Immunol 182:329–39PubMedGoogle Scholar
  46. 46.
    Dintzis RZ, Middleton MH, and Dintzis HM (1983) Studies on the immunogenicity and tolerogenicity of T-independent antigens. J Immunol 131:2196–203PubMedGoogle Scholar
  47. 47.
    Bachmann MF, Hengartner H, and Zinkernagel RM (1995) T helper cell-independent neutralizing B cell response against vesicular stomatitis virus: role of antigen patterns in B cell induction? Eur J Immunol 25:3445–51PubMedGoogle Scholar
  48. 48.
    Fehr T, Skrastina D, Pumpens P, and Zinkernagel RM (1998) T cell-independent type I antibody response against B cell epitopes expressed repetitively on recombinant virus particles. Proc Natl Acad Sci USA 95:9477–81PubMedGoogle Scholar
  49. 49.
    Jegerlehner A, Storni T, Lipowsky G, Schmid M, Pumpens P, and Bachmann MF (2002) Regulation of IgG antibody responses by epitope density and CD21-mediated costimulation. Eur J Immunol 32:3305–14PubMedGoogle Scholar
  50. 50.
    Yang R, Murillo FM, Delannoy MJ, Blosser RL, Yutzy WHt, Uematsu S, Takeda K, Akira S, Viscidi RP, and Roden RB (2005) B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88. J Immunol 174:7912–9PubMedGoogle Scholar
  51. 51.
    Cohen-Sfady M, Nussbaum G, Pevsner-Fischer M, Mor F, Carmi P, Zanin-Zhorov A, Lider O, and Cohen IR (2005) Heat shock protein 60 activates B cells via the TLR4-MyD88 pathway. J Immunol 175:3594–602PubMedGoogle Scholar
  52. 52.
    Dimmock NJ and Hardy SA (2004) Valency of antibody binding to virions and its determination by surface plasmon resonance. Rev Med Virol 14:123–35PubMedGoogle Scholar
  53. 53.
    Hinton HJ, Jegerlehner A, and Bachmann MF (2008) Pattern recognition by B cells: the role of antigen repetitiveness versus Toll-like receptors. Curr Top Microbiol Immunol 319: 1–15PubMedGoogle Scholar
  54. 54.
    Gruijthuijsen YK, Grieshuber I, Stocklinger A, Tischler U, Fehrenbach T, Weller MG, Vogel L, Vieths S, Poschl U, and Duschl A (2006) Nitration enhances the allergenic potential of proteins. Int Arch Allergy Immunol 141:265–75PubMedGoogle Scholar
  55. 55.
    Hoffmann-Sommergruber K (2002) Pathogenesis-related (PR)-proteins identified as allergens. Biochem Soc Trans 30:930–35PubMedGoogle Scholar
  56. 56.
    Roth-Walter F, Berin MC, Arnaboldi P, Escalante CR, Dahan S, Rauch J, Jensen-Jarolim E, and Mayer L (2008) Pasteurization of milk proteins promotes allergic sensitization by enhancing uptake through Peyer’s patches. Allergy 63:882–90PubMedGoogle Scholar
  57. 57.
    Vos Q, Lees A, Wu ZQ, Snapper CM, and Mond JJ (2000) B-cell activation by T-cell-independent type 2 antigens as an integral part of the humoral immune response to pathogenic microorganisms. Immunol Rev 176:154–70PubMedGoogle Scholar
  58. 58.
    Pasare C and Medzhitov R (2005) Control of B-cell responses by Toll-like receptors. Nature 438:364–68PubMedGoogle Scholar
  59. 59.
    Traidl-Hoffmann C, Mariani V, Hochrein H, Karg K, Wagner H, Ring J, Mueller MJ, Jakob T, and Behrendt H (2005) Pollen-associated phytoprostanes inhibit dendritic cell interleukin-12 production and augment T helper type 2 cell polarization. J Exp Med 201:627–36PubMedGoogle Scholar
  60. 60.
    Brunner R, Wallmann J, Szalai K, Karagiannis P, Altmeppen H, Riemer AB, Jensen-Jarolim E, and Pali-Scholl I (2009) Aluminium per se and in the anti-acid drug sucralfate promotes sensitization via the oral route. Allergy 64:890–7Google Scholar
  61. 61.
    Brunner R, Wallmann J, Szalai K, Karagiannis P, Kopp T, Scheiner O, Jensen-Jarolim E, and Pali-Scholl I (2007) The impact of aluminium in acid-suppressing drugs on the immune response of BALB/c mice. Clin Exp Allergy 37:1566–73PubMedGoogle Scholar
  62. 62.
    Sato M, Adachi T, and Tsubata T (2007) Augmentation of signaling through BCR containing IgE but not that containing IgA due to lack of CD22-mediated signal regulation. J Immunol 178:2901–7PubMedGoogle Scholar
  63. 63.
    Segal DM, Taurog JD, and Metzger H (1977) Dimeric immunoglobulin E serves as a unit signal for mast cell degranulation. Proc Natl Acad Sci USA 74:2993–7PubMedGoogle Scholar
  64. 64.
    Asai K, Kitaura J, Kawakami Y, Yamagata N, Tsai M, Carbone DP, Liu FT, Galli SJ, and Kawakami T (2001) Regulation of mast cell survival by IgE. Immunity 14:791–800PubMedGoogle Scholar
  65. 65.
    Yamasaki S, Ishikawa E, Kohno M, and Saito T (2004) The quantity and duration of FcRgamma signals determine mast cell degranulation and survival. Blood 103:3093–101PubMedGoogle Scholar
  66. 66.
    Maurer D, Fiebiger E, Reininger B, Ebner C, Petzelbauer P, Shi GP, Chapman HA, and Stingl G (1998) Fc epsilon receptor I on dendritic cells delivers IgE-bound multivalent antigens into a cathepsin S-dependent pathway of MHC class II presentation. J Immunol 161:2731–9PubMedGoogle Scholar
  67. 67.
    Shapira SK, Jabara HH, Thienes CP, Ahern DJ, Vercelli D, Gould HJ, and Geha RS (1991) Deletional switch recombination occurs in interleukin-4-induced isotype switching to IgE expression by human B cells. Proc Natl Acad Sci USA 88:7528–32PubMedGoogle Scholar
  68. 68.
    Jabara HH, Loh R, Ramesh N, Vercelli D, and Geha RS (1993) Sequential switching from mu to epsilon via gamma 4 in human B cells stimulated with IL-4 and hydrocortisone. J Immunol 151:4528–33PubMedGoogle Scholar
  69. 69.
    Scholl I, Kalkura N, Shedziankova Y, Bergmann A, Verdino P, Knittelfelder R, Kopp T, Hantusch B, Betzel C, Dierks K, Scheiner O, Boltz-Nitulescu G, Keller W, and Jensen-Jarolim E (2005) Dimerization of the major birch pollen allergen Bet v 1 is important for its in vivo IgE-cross-linking potential in mice. J Immunol 175:6645–50PubMedGoogle Scholar
  70. 70.
    Mongini PK, Blessinger CA, Highet PF, and Inman JK (1992) Membrane IgM-mediated signaling of human B cells. Effect of increased ligand binding site valency on the affinity and concentration requirements for inducing diverse stages of activation. J Immunol 148: 3892–901PubMedGoogle Scholar
  71. 71.
    Kouskoff V, Famiglietti S, Lacaud G, Lang P, Rider JE, Kay BK, Cambier JC, and Nemazee D (1998) Antigens varying in affinity for the B cell receptor induce differential B lymphocyte responses. J Exp Med 188:1453–64PubMedGoogle Scholar
  72. 72.
    Katz DH, Hamaoka T, and Benacerraf B (1973) Induction of immunological tolerance in bone marrow-derived lymphocytes of the IgE antibody class. Proc Natl Acad Sci USA 70:2776–80PubMedGoogle Scholar
  73. 73.
    Rivera J, Cordero JR, Furumoto Y, Luciano-Montalvo C, Gonzalez-Espinosa C, Kovarova M, Odom S, and Parravicini V (2002) Macromolecular protein signaling complexes and mast cell responses: a view of the organization of IgE-dependent mast cell signaling. Mol Immunol 38:1253–8PubMedGoogle Scholar
  74. 74.
    Okumura S, Kashiwakura J, Tomita H, Matsumoto K, Nakajima T, Saito H, and Okayama Y (2003) Identification of specific gene expression profiles in human mast cells mediated by Toll-like receptor 4 and FcepsilonRI. Blood 102:2547–54PubMedGoogle Scholar
  75. 75.
    Kawakami T and Galli SJ (2002) Regulation of mast-cell and basophil function and survival by IgE. Nat Rev Immunol 2:773–86PubMedGoogle Scholar
  76. 76.
    Furuichi K, Rivera J, and Isersky C (1985) The receptor for immunoglobulin E on rat basophilic leukemia cells: effect of ligand binding on receptor expression. Proc Natl Acad Sci USA 82:1522–5PubMedGoogle Scholar
  77. 77.
    Yamaguchi M, Lantz CS, Oettgen HC, Katona IM, Fleming T, Miyajima I, Kinet JP, and Galli SJ (1997) IgE enhances mouse mast cell Fc(epsilon)RI expression in vitro and in vivo: evidence for a novel amplification mechanism in IgE-dependent reactions. J Exp Med 185:663–72PubMedGoogle Scholar
  78. 78.
    Holowka D, Sil D, Torigoe C, and Baird B (2007) Insights into immunoglobulin E receptor signaling from structurally defined ligands. Immunol Rev 217:269–79PubMedGoogle Scholar
  79. 79.
    Kane PM, Holowka D, and Baird B (1988) Cross-linking of IgE-receptor complexes by rigid bivalent antigens greater than 200 A in length triggers cellular degranulation. J Cell Biol 107:969–80PubMedGoogle Scholar
  80. 80.
    Paar JM, Harris NT, Holowka D, and Baird B (2002) Bivalent ligands with rigid double-stranded DNA spacers reveal structural constraints on signaling by Fc epsilon RI. J Immunol 169:856–64PubMedGoogle Scholar
  81. 81.
    Perez-Montfort R and Metzger H (1982) Proteolysis of soluble IgE-receptor complexes: localization of sites on IgE which interact with the Fc receptor. Mol Immunol 19:1113–25PubMedGoogle Scholar
  82. 82.
    Wan T, Beavil RL, Fabiane SM, Beavil AJ, Sohi MK, Keown M, Young RJ, Henry AJ, Owens RJ, Gould HJ, and Sutton BJ (2002) The crystal structure of IgE Fc reveals an asymmetrically bent conformation. Nat Immunol 3:681–6PubMedGoogle Scholar
  83. 83.
    Zheng Y, Shopes B, Holowka D, and Baird B (1991) Conformations of IgE bound to its receptor Fc epsilon RI and in solution. Biochemistry 30:9125–32PubMedGoogle Scholar
  84. 84.
    Zheng Y, Shopes B, Holowka D, and Baird B (1992) Dynamic conformations compared for IgE and IgG1 in solution and bound to receptors. Biochemistry 31:7446–56PubMedGoogle Scholar
  85. 85.
    Becker KE, Ishizaka T, Metzger H, Ishizaka K, and Grimley PM (1973) Surface IgE on human basophils during histamine release. J Exp Med 138:394–409PubMedGoogle Scholar
  86. 86.
    Hook WA, Siraganian RP, and Wahl SM (1975) Complement-induced histamine release from human basophils. I. Generation of activity in human serum. J Immunol 114:1185–90PubMedGoogle Scholar
  87. 87.
    Yamashita T, Yamaguchi T, Murakami K, and Nagasawa S (2001) Detergent-resistant membrane domains are required for mast cell activation but dispensable for tyrosine phosphorylation upon aggregation of the high affinity receptor for IgE. J Biochem 129: 861–8PubMedGoogle Scholar
  88. 88.
    Schweitzer-Stenner R, Licht A, Luscher I, and Pecht I (1987) Oligomerization and ring closure of immunoglobulin E class antibodies by divalent haptens. Biochemistry 26: 3602–12PubMedGoogle Scholar
  89. 89.
    Janeway CA Jr and Medzhitov R (2002) Innate immune recognition. Annu Rev Immunol 20:197–216PubMedGoogle Scholar
  90. 90.
    King TP, Kochoumian L, and Joslyn A (1984) Melittin-specific monoclonal and polyclonal IgE and IgG1 antibodies from mice. J Immunol 133:2668–73PubMedGoogle Scholar
  91. 91.
    Rafnar T, Brummet ME, Bassolino-Klimas D, Metzler WJ, and Marsh DG (1998) Analysis of the three-dimensional antigenic structure of giant ragweed allergen, Amb t 5. Mol Immunol 35:459–67PubMedGoogle Scholar
  92. 92.
    Jensen-Jarolim E, Leitner A, Kalchhauser H, Zurcher A, Ganglberger E, Bohle B, Scheiner O, Boltz-nitulescu G, and Breiteneder H (1998) Peptide mimotopes displayed by phage inhibit antibody binding to bet v 1, the major birch pollen allergen, and induce specific IgG response in mice. FASEB J 12:1635–42PubMedGoogle Scholar
  93. 93.
    Spangfort MD, Mirza O, Ipsen H, Van Neerven RJ, Gajhede M, and Larsen JN (2003) Dominating IgE-binding epitope of Bet v 1, the major allergen of birch pollen, characterized by X-ray crystallography and site-directed mutagenesis. J Immunol 171:3084–90PubMedGoogle Scholar
  94. 94.
    Ganglberger E, Grunberger K, Sponer B, Radauer C, Breiteneder H, Boltz-Nitulescu G, Scheiner O, and Jensen-Jarolim E (2000) Allergen mimotopes for 3-dimensional epitope search and induction of antibodies inhibiting human IgE. Faseb J 14:2177–84PubMedGoogle Scholar
  95. 95.
    Habermann E (1972) Bee and wasp venoms. Science 177:314–22PubMedGoogle Scholar
  96. 96.
    Terwilliger TC, Weissman L, and Eisenberg D (1982) The structure of melittin in the form I crystals and its implication for melittin’s lytic and surface activities. Biophys J 37:353–61PubMedGoogle Scholar
  97. 97.
    Ghosh D and Gupta-Bhattacharya S (2008) Structural insight into protein T1, the non-allergenic member of the Bet v 1 allergen family-An in silico analysis. Mol Immunol 45:456–62PubMedGoogle Scholar
  98. 98.
    Christensen LH, Holm J, Lund G, Riise E, and Lund K (2008) Several distinct properties of the IgE repertoire determine effector cell degranulation in response to allergen challenge. J Allergy Clin Immunol 122:298–304PubMedGoogle Scholar
  99. 99.
    Gieras A, Focke-Tejkl M, Ball T, Verdino P, Hartl A, Thalhamer J, and Valenta R (2007) Molecular determinants of allergen-induced effector cell degranulation. J Allergy Clin Immunol 119:384–90PubMedGoogle Scholar
  100. 100.
    Pierson-Mullany LK, Jackola DR, Blumenthal MN, and Rosenberg A (2000) Characterization of polyclonal allergen-specific IgE responses by affinity distributions. Mol Immunol 37:613–20PubMedGoogle Scholar
  101. 101.
    Hantusch B, Schöll I, Harwanegg C, Krieger S, Becker WM, Spitzauer S, Boltz-Nitulescu G, and Jensen-Jarolim E (2005) Affinity determinations of purified IgE and IgG antibodies against the major pollen allergens Phl p 5a and Bet v 1a: discrepancy between IgE and IgG binding strength. Immunol Lett 97:81–9PubMedGoogle Scholar
  102. 102.
    Reese G, Ayuso R, and Lehrer SB (1999) Tropomyosin: an invertebrate pan-allergen. Int Arch Allergy Immunol 119:247–58PubMedGoogle Scholar
  103. 103.
    Bellinghausen I, Haringer B, Lafargue B, Strand D, Konig B, Decker H, and Saloga J (2008) Allergological implication of the quaternary hexameric structure of the cockroach allergen Per a 3. Clin Exp Allergy 38:539–48PubMedGoogle Scholar
  104. 104.
    Smole U, Balazs N, Hoffmann-Sommergruber K, Breiteneder H, and Wagner S (2008) Different polarization of Th responses by dendritic cells (DCs) of birch pollen allergic and non atopic donors pulsed with Bet v 1 and homologous food allergens (XXVII Congress of the European Academy of Allergology and Clinical Immunology, June 7–11, 2008, Barcelona, Spain). Allergy 63:255Google Scholar
  105. 105.
    van Boxtel EL, van Beers MM, Koppelman SJ, van den Broek LA, and Gruppen H (2006) Allergen Ara h 1 occurs in peanuts as a large oligomer rather than as a trimer. J Agric Food Chem 54:7180–6PubMedGoogle Scholar
  106. 106.
    Beezhold DH, Hickey VL, Sutherland MF, and O’Hehir RE (2004) The latex allergen hev B 5 is an antigen with repetitive murine B-cell epitopes. Int Arch Allergy Immunol 134:334–40PubMedGoogle Scholar
  107. 107.
    Pomes A, Vailes LD, Helm RM, and Chapman MD (2002) IgE reactivity of tandem repeats derived from cockroach allergen, Bla g 1. Eur J Biochem 269:3086–92PubMedGoogle Scholar
  108. 108.
    Ayuso R, Lehrer SB, and Reese G (2002) Identification of continuous, allergenic regions of the major shrimp allergen Pen a 1 (tropomyosin). Int Arch Allergy Immunol 127:27–37PubMedGoogle Scholar
  109. 109.
    Marti P, Truffer R, Stadler MB, Keller-Gautschi E, Crameri R, Mari A, Schmid-Grendelmeier P, Miescher SM, Stadler BM, and Vogel M (2007) Allergen motifs and the prediction of allergenicity. Immunol Lett 109:47–55PubMedGoogle Scholar
  110. 110.
    Stadler MB and Stadler BM (2003) Allergenicity prediction by protein sequence. Faseb J 17:1141–43PubMedGoogle Scholar
  111. 111.
    Kong W, Tan TS, Tham L, and Choo KW (2007) Improved prediction of allergenicity by combination of multiple sequence motifs. In Silico Biol 7:77–86PubMedGoogle Scholar
  112. 112.
    Cooke MP, Heath AW, Shokat KM, Zeng Y, Finkelman FD, Linsley PS, Howard M, and Goodnow CC (1994) Immunoglobulin signal transduction guides the specificity of B cell-T cell interactions and is blocked in tolerant self-reactive B cells. J Exp Med 179:425–38PubMedGoogle Scholar
  113. 113.
    Lindblom A and Liljegren A (2000) Regular review: tumour markers in malignancies. Bmj 320:424–27PubMedGoogle Scholar
  114. 114.
    Wu JT (2002) C-erbB2 oncoprotein and its soluble ectodomain: a new potential tumor marker for prognosis early detection and monitoring patients undergoing Herceptin treatment. Clin Chim Acta 322:11–9PubMedGoogle Scholar
  115. 115.
    Voorzanger-Rousselot N and Garnero P (2007) Biochemical markers in oncology. Part I: molecular basis. Part II: clinical uses. Cancer Treat Rev 33:230–83PubMedGoogle Scholar
  116. 116.
    Kurien BT and Scofield RH (2008) Autoimmunity and oxidatively modified autoantigens. Autoimmun Rev 7:567–73PubMedGoogle Scholar
  117. 117.
    Banerjea A, Feakins RM, Nickols CD, Phillips SM, Powar MP, Bustin SA, and Dorudi S (2005) Immunogenic hsp-70 is overexpressed in colorectal cancers with high-degree microsatellite instability. Dis Colon Rectum 48:2322–28PubMedGoogle Scholar
  118. 118.
    Yasuda M, Takenoyama M, Obata Y, Sugaya M, So T, Hanagiri T, Sugio K, and Yasumoto K (2002) Tumor-infiltrating B lymphocytes as a potential source of identifying tumor antigen in human lung cancer. Cancer Res 62:1751–56PubMedGoogle Scholar
  119. 119.
    Taylor RB, Duffus WPH, Raff MC, and de Petris S (1971) Redistribution and pinocytosis of lymphocyte surface immunoglobulin molecules induced by anti immunoglobulin antibody. (New Biology) Nature 233:225–9Google Scholar
  120. 120.
    Pecanha LM, Snapper CM, Finkelman FD, and Mond JJ (1991) Dextran-conjugated anti-Ig antibodies as a model for T cell-independent type 2 antigen-mediated stimulation of Ig secretion in vitro. I. Lymphokine dependence. J Immunol 146:833–9PubMedGoogle Scholar
  121. 121.
    Schwartz-Albiez R, Laban S, Eichmuller S, and Kirschfink M (2008) Cytotoxic natural antibodies against human tumours: an option for anti-cancer immunotherapy? Autoimmun Rev 7:491–5PubMedGoogle Scholar
  122. 122.
    Cheng ZJ, Singh RD, Marks DL, and Pagano RE (2006) Membrane microdomains, caveolae, and caveolar endocytosis of sphingolipids. Mol Membr Biol 23:101–10PubMedGoogle Scholar
  123. 123.
    Brown DA (2006) Lipid rafts, detergent-resistant membranes, and raft targeting signals. Physiology (Bethesda) 21:430–9Google Scholar
  124. 124.
    Nagy P, Vereb G, Sebestyen Z, Horvath G, Lockett SJ, Damjanovich S, Park JW, Jovin TM, and Szollosi J (2002) Lipid rafts and the local density of ErbB proteins influence the biological role of homo- and heteroassociations of ErbB2. J Cell Sci 115:4251–62PubMedGoogle Scholar
  125. 125.
    Rodriguez GC, Boente MP, Berchuck A, Whitaker RS, O’Briant KC, Xu F, and Bast RC Jr (1993) The effect of antibodies and immunotoxins reactive with HER-2/neu on growth of ovarian and breast cancer cell lines. Am J Obstet Gynecol 168:228–32PubMedGoogle Scholar
  126. 126.
    Milenic DE, Garmestani K, Brady ED, Albert PS, Ma D, Abdulla A, and Brechbiel MW (2004) Targeting of HER2 antigen for the treatment of disseminated peritoneal disease. Clin Cancer Res 10:7834–41PubMedGoogle Scholar
  127. 127.
    Ozcelik S, Orr G, Hu D, Chen C-S, Resat H, Harms GS, Opresko LK, Wiley HS, and Colson SD (2004) FRET measurements between small numbers of molecules identifies subtle changes in receptor interactions. Proc SPIE 5323:119Google Scholar
  128. 128.
    Webb SE, Roberts SK, Needham SR, Tynan CJ, Rolfe DJ, Winn MD, Clarke DT, Barraclough R, and Martin-Fernandez ML (2008) Single-molecule imaging and fluorescence lifetime imaging microscopy show different structures for high- and low-affinity epidermal growth factor receptors in A431 cells. Biophys J 94:803–19PubMedGoogle Scholar
  129. 129.
    Orr G, Hu D, Ozcelik S, Opresko LK, Wiley HS, and Colson SD (2005) Cholesterol dictates the freedom of EGF receptors and HER2 in the plane of the membrane. Biophys J 89: 1362–73PubMedGoogle Scholar
  130. 130.
    Dessi S, Batetta B, Pulisci D, Spano O, Anchisi C, Tessitore L, Costelli P, Baccino FM, Aroasio E, and Pani P (1994) Cholesterol content in tumor tissues is inversely associated with high-density lipoprotein cholesterol in serum in patients with gastrointestinal cancer. Cancer 73:253–8PubMedGoogle Scholar
  131. 131.
    Skornick Y, Kurman CC, and Sindelar WF (1984) Active immunization of hamsters against pancreatic carcinoma with lipid-treated cells or their shed antigens. Cancer Res 44: 946–8PubMedGoogle Scholar
  132. 132.
    Wang XQ and Paller AS (2006) Lipid rafts: membrane triage centers. J Invest Dermatol 126:951–3PubMedGoogle Scholar
  133. 133.
    Chen X and Resh MD (2002) Cholesterol depletion from the plasma membrane triggers ligand-independent activation of the epidermal growth factor receptor. J Biol Chem 277:49631–7PubMedGoogle Scholar
  134. 134.
    Shinitzky M, Skornick Y, and Haran-Ghera N (1979) Effective tumor immunization induced by cells of elevated membrane-lipid microviscosity. Proc Natl Acad Sci USA 76:5313–6PubMedGoogle Scholar
  135. 135.
    Winiarska M, Bil J, Wilczek E, Wilczynski GM, Lekka M, Engelberts PJ, Mackus WJ, Gorska E, Bojarski L, Stoklosa T, Nowis D, Kurzaj Z, Makowski M, Glodkowska E, Issat T, Mrowka P, Lasek W, Dabrowska-Iwanicka A, Basak GW, Wasik M, Warzocha K, Sinski M, Gaciong Z, Jakobisiak M, Parren PW, and Golab J (2008) Statins impair antitumor effects of rituximab by inducing conformational changes of CD20. PLoS Med 5:e64PubMedGoogle Scholar
  136. 136.
    Janas E, Priest R, Wilde JI, White JH, and Malhotra R (2005) Rituxan (anti-CD20 antibody)-induced translocation of CD20 into lipid rafts is crucial for calcium influx and apoptosis. Clin Exp Immunol 139:439–46PubMedGoogle Scholar
  137. 137.
    Janas E, Priest R, and Malhotra R (2005) Functional role of lipid rafts in CD20 activity? Biochem Soc Symp:165–75Google Scholar
  138. 138.
    Chaturvedi P, Singh AP, and Batra SK (2008) Structure, evolution, and biology of the MUC4 mucin. Faseb J 22:966–81PubMedGoogle Scholar
  139. 139.
    Chaturvedi P, Singh AP, Chakraborty S, Chauhan SC, Bafna S, Meza JL, Singh PK, Hollingsworth MA, Mehta PP, and Batra SK (2008) MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. Cancer Res 68:2065–70PubMedGoogle Scholar
  140. 140.
    Aas K, and Jebsen JW (1967) Studies of hypersensitivity to fish. Partial purification and crystallization of a major allergenic component of cod. Int Arch Allergy Appl Immunol 32:1–20PubMedGoogle Scholar
  141. 141.
    Huecas S, Villalba M, and Rodriguez R (2001) Ole e 9, a major olive pollen allergen is a 1,3-beta-glucanase. Isolation, characterization, amino acid sequence, and tissue specificity. J Biol Chem 276:27959–66PubMedGoogle Scholar
  142. 142.
    McGibbon AM, Christie JF, Kennedy MW, and Lee TD (1990) Identification of the major Ascaris allergen and its purification to homogeneity by high-performance liquid chromatography. Mol Biochem Parasitol 39:163–71PubMedGoogle Scholar
  143. 143.
    Bocskei Z, Groom CR, Flower DR, Wright CE, Phillips SE, Cavaggioni A, Findlay JB, and North AC (1992) Pheromone binding to two rodent urinary proteins revealed by X-ray crystallography. Nature 360:186–8PubMedGoogle Scholar
  144. 144.
    Ogawa T, Tsuji H, Bando N, Kitamura K, Zhu YL, Hirano H, and Nishikawa K (1993) Identification of the soybean allergenic protein, Gly m Bd 30 K, with the soybean seed 34-kDa oil-body-associated protein. Biosci Biotechnol Biochem 57:1030–3PubMedGoogle Scholar
  145. 145.
    Hoffman DR (1993) Allergens in Hymenoptera venom XXIV: the amino acid sequences of imported fire ant venom allergens Sol i II, Sol i III, and Sol i IV. J Allergy Clin Immunol 91:71–8PubMedGoogle Scholar
  146. 146.
    Gimona M, Watakabe A, and Helfman DM (1995) Specificity of dimer formation in tropomyosins: influence of alternatively spliced exons on homodimer and heterodimer assembly. Proc Natl Acad Sci USA 92:9776–80PubMedGoogle Scholar
  147. 147.
    De Vouge MW, Thaker AJ, Curran IH, Zhang L, Muradia G, Rode H, and Vijay HM (1996) Isolation and expression of a cDNA clone encoding an Alternaria alternata Alt a 1 subunit. Int Arch Allergy Immunol 111:385–95PubMedGoogle Scholar
  148. 148.
    Wellhausen A, Schoning B, Petersen A, and Vieths S (1996) IgE binding to a new cross-reactive structure: a 35 kDa protein in birch pollen, exotic fruit and other plant foods. Z Ernahrungswiss 35:348–55PubMedGoogle Scholar
  149. 149.
    Rautiainen J, Pentikainen J, Rytkonen M, Linnala-Kankkunen A, Pelkonen J, Virtanen T, and Mantyjarvi R (1996) Molecular analysis of allergenic proteins in bovine dander. Allergy 51:378–82PubMedGoogle Scholar
  150. 150.
    Shin DS, Compadre CM, Maleki SJ, Kopper RA, Sampson H, Huang SK, Burks AW, and Bannon GA (1998) Biochemical and structural analysis of the IgE binding sites on Ara h1, an abundant and highly allergenic peanut protein. J Biol Chem 273:13753–9PubMedGoogle Scholar
  151. 151.
    Petersen A, Schramm G, Schlaak M, and Becker WM (1998) Post-translational modifications influence IgE reactivity to the major allergen Phl p 1 of timothy grass pollen. Clin Exp Allergy 28:315–21PubMedGoogle Scholar
  152. 152.
    Eriksson TL, Whitley P, Johansson E, van Hage-Hamsten M, and Gafvelin G (1999) Identification and characterisation of two allergens from the dust mite Acarus siro, homologous with fatty acid-binding proteins. Int Arch Allergy Immunol 119:275–81PubMedGoogle Scholar
  153. 153.
    Gregoire C, Tavares GA, Lorenzo HK, Dandeu JP, David B, and Alzari PM (1999) Crystallization and preliminary crystallographic analysis of the major horse allergen Equ c 1. Acta Crystallogr D Biol Crystallogr 55(Pt 4):880–2PubMedGoogle Scholar
  154. 154.
    Xia Y, Spence HJ, Moore J, Heaney N, McDermott L, Cooper A, Watson DG, Mei B, Komuniecki R, and Kennedy MW (2000) The ABA-1 allergen of Ascaris lumbricoides: sequence polymorphism, stage and tissue-specific expression, lipid binding function, and protein biophysical properties. Parasitology 120(Pt 2):211–24PubMedGoogle Scholar
  155. 155.
    Maleki SJ, Kopper RA, Shin DS, Park CW, Compadre CM, Sampson H, Burks AW, and Bannon GA (2000) Structure of the major peanut allergen Ara h 1 may protect IgE-binding epitopes from degradation. J Immunol 164:5844–9PubMedGoogle Scholar
  156. 156.
    Lascombe MB, Gregoire C, Poncet P, Tavares GA, Rosinski-Chupin I, Rabillon J, Goubran-Botros H, Mazie JC, David B, and Alzari PM (2000) Crystal structure of the allergen Equ c 1. A dimeric lipocalin with restricted IgE-reactive epitopes. J Biol Chem 275: 21572–7PubMedGoogle Scholar
  157. 157.
    Suck R, Weber B, Kahlert H, Hagen S, Cromwell O, and Fiebig H (2000) Purification and immunobiochemical characterization of folding variants of the recombinant major wasp allergen Ves v 5 (antigen 5). Int Arch Allergy Immunol 121:284–91PubMedGoogle Scholar
  158. 158.
    Sakurai K, Oobatake M, and Goto Y (2001) Salt-dependent monomer-dimer equilibrium of bovine beta-lactoglobulin at pH 3. Protein Sci 10:2325–35PubMedGoogle Scholar
  159. 159.
    Sen M, Kopper R, Pons L, Abraham EC, Burks AW, and Bannon GA (2002) Protein structure plays a critical role in peanut allergen stability and may determine immunodominant IgE-binding epitopes. J Immunol 169:882–7PubMedGoogle Scholar
  160. 160.
    Das Dores S, Chopin C, Villaume C, Fleurence J, and Gueant JL (2002) A new oligomeric parvalbumin allergen of Atlantic cod (Gad mI) encoded by a gene distinct from that of Gad cI. Allergy 57(Suppl 72):79–83PubMedGoogle Scholar
  161. 161.
    Rajashankar K, Bufe A, Weber W, Eschenburg S, Lindner B, and Betzel C (2002) Structure of the functional domain of the major grass-pollen allergen Phlp 5b. Acta Crystallogr D Biol Crystallogr 58:1175–81PubMedGoogle Scholar
  162. 162.
    Verdino P, Westritschnig K, Valenta R, and Keller W (2002) The cross-reactive calcium-binding pollen allergen, Phl p 7, reveals a novel dimer assembly. Embo J 21:5007–16PubMedGoogle Scholar
  163. 163.
    Wopfner N, Willeroidee M, Hebenstreit D, van Ree R, Aalbers M, Briza P, Thalhamer J, Ebner C, Richter K, and Ferreira F (2002) Molecular and immunological characterization of profilin from mugwort pollen. Biol Chem 383:1779–89PubMedGoogle Scholar
  164. 164.
    Fahlbusch B, Rudeschko O, Schlott B, Henzgen M, Schlenvoigt G, Schubert H, and Kinne RW (2003) Further characterization of IgE-binding antigens from guinea pig hair as new members of the lipocalin family. Allergy 58:629–34PubMedGoogle Scholar
  165. 165.
    Gronlund H, Bergman T, Sandstrom K, Alvelius G, Reininger R, Verdino P, Hauswirth A, Liderot K, Valent P, Spitzauer S, Keller W, Valenta R, and van Hage-Hamsten M (2003) Formation of disulfide bonds and homodimers of the major cat allergen Fel d 1 equivalent to the natural allergen by expression in Escherichia coli. J Biol Chem 278: 40144–51PubMedGoogle Scholar
  166. 166.
    van Oort E, Dieker MC, de Heer PG, Peltre G, Aalberse RC, and van Ree R (2005) The major grass pollen group 5 allergen from Dactylis glomerata and its C-terminal split product both behave as dimers: implications for allergen standardization. Int Arch Allergy Immunol 136:113–22PubMedGoogle Scholar
  167. 167.
    de Halleux S, Stura E, VanderElst L, Carlier V, Jacquemin M, and Saint-Remy JM (2006) Three-dimensional structure and IgE-binding properties of mature fully active Der p 1, a clinically relevant major allergen. J Allergy Clin Immunol 117:571–6PubMedGoogle Scholar
  168. 168.
    Ball T, Leistler B, Valenta R, and Almo SC (2003) X-ray crystal structure of Phl p 1, a major timothy grass pollen allergen. RCSB Protein Data Bank 1N10Google Scholar
  169. 169.
    Kamata Y, Miyanomae A, Nakayama E, Miyanomae T, Tajima T, Nishimura K, Tada T, and Hoshi H (2007) Characterization of dog allergens Can f 1 and Can f 2. 2. A comparison of Can f 1 with Can f 2 regarding their biochemical and immunological properties. Int Arch Allergy Immunol 142:301–8PubMedGoogle Scholar
  170. 170.
    Li M, Gustchina A, Alexandratos J, Wlodawer A, Wunschmann S, Kepley CL, Chapman MD, and Pomes A (2008) Crystal structure of a dimerized cockroach allergen Bla g 2 complexed with a monoclonal antibody. J Biol Chem 283:22806–14PubMedGoogle Scholar
  171. 171.
    Weghofer M, Dall’Antonia Y, Grote M, Stocklinger A, Kneidinger M, Balic N, Krauth MT, Fernandez-Caldas E, Thomas WR, van Hage M, Vieths S, Spitzauer S, Horak F, Svergun DI, Konarev PV, Valent P, Thalhamer J, Keller W, Valenta R, and Vrtala S (2008) Characterization of Der p 21, a new important allergen derived from the gut of house dust mites. Allergy 63:758–67PubMedGoogle Scholar
  172. 172.
    Tan YW, Chan SL, Ong TC, Yit le Y, Tiong YS, Chew FT, Sivaraman J, and Mok YK (2009) Structures of Two Major Allergens, Bla g 4 and Per a 4, from Cockroaches and Their IgE Binding Epitopes. J Biol Chem 284:3148–57PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Erika Jensen-Jarolim
    • 1
    Email author
  • Diana Mechtcheriakova
    • 1
  • Isabella Pali-Schoell
    • 1
  1. 1.IPP – Department of Pathophysiology, Center of Pathophysiology, Infectiology and ImmunologyMedical University ViennaViennaAustria

Personalised recommendations